Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Sunday, March 29, 2015

Brainstorm Cell Therapeutics Given "Buy" Rating at Maxim Group

's stock had its "buy" rating reissued by investment analysts at Maxim Group in a note issued to investors on Sunday. They currently have a $14.00 target price on the stock.

http://ift.tt/1a6Qy7N

No comments:

Post a Comment

Popular Stem Cell Roundup Posts